Transcript of video
Hello from London! Dr. Anton Titov, MD. We are with Professor Sir Mark Pepys. He is the Director, Wolfson Drug Discovery Unit, Centre for Amyloidosis at the University College London. Professor Dr. Mark Pepys, MD, is a global expert in amyloidosis. Amyloidosis is a fatal disease resulting from amyloid deposits in many organs and tissues. Amyloid is also a key factor in Alzheimer’s disease. Professor Pepys was educated at Trinity College Cambridge and University College Hospital Medical School, London. Professor Dr. Mark Pepys, MD, returned to Cambridge as a research scholar for his PhD in immunology. He spent 22 years as Head of the Immunological Medicine Unit at the Royal Postgraduate Medical School. Professor Dr. Mark Pepys, MD. became Professor and Head of the Department of Medicine at the Royal Free Campus of University College London. Professor Pepys have done groundbreaking work on amyloidosis treatment. He continues to do research and clinical work to extend his therapy to the treatment of Alzheimer’s disease. His accomplishments have been recognized by numerous awards and memberships. Professor Dr. Mark Pepys, MD, is a Fellow of the Royal Society, a Founder Fellow of the Academy of Medical Sciences. In 2012 he was created Knight Bachelor [“Sir”] for his services to biomedicine. Dr. Anton Titov, MD. Professor Pepys, hello and welcome! Thank you!